查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1919296

醫用心臟環狀成形術環市場（按環形狀、產品類型、手術類型、材質類型、應用和最終用戶分類）—2026-2032年全球預測

Medical Heart Annuloplasty Ring Market by Ring Shape, Product Type, Procedure Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，醫用心臟環狀成形術環市場價值為 4.4889 億美元，預計到 2026 年將成長至 4.735 億美元，年複合成長率為 4.28%，到 2032 年將達到 6.0218 億美元。

關鍵市場統計數據
基準年 2025 4.4889億美元
預計年份：2026年 4.735億美元
預測年份 2032 6.0218億美元
複合年成長率 (%) 4.28%

策略概述，介紹了影響環狀成形術環環發展和應用的臨床因素、器械設計演變以及醫療保健系統趨勢。

本執行摘要概述了環狀成形術環環的策略考量，重點在於臨床創新、不斷發展的器械設計和不斷演變的治療路徑。它整合了當前的實踐模式、器械差異化以及相關人員的獎勵，為經營團隊決策提供清晰的基礎。分析優先考慮臨床促進因素，例如對保留瓣膜療法的日益青睞、促進生物相容性的材料科學進步，以及旨在降低圍手術全期風險和加速患者康復的微創手術方式的轉變。

器械設計、手術流程創新和臨床培訓的進步正在匯聚，重新定義人們對環狀成形術環的期望和應用路徑。

環狀成形術環市場格局正經歷一場變革，其驅動力包括技術改進、手術創新以及臨床醫師偏好的轉變。瓣環幾何形狀和材料科學的進步使得瓣環成形環的設計能夠更精確地模擬天然瓣環的動態特性，從而提高修復的耐久性和功能效果。同時，手術創新正在加速微創手術的普及，而外科技術與輔助影像技術的結合，則使得瓣膜修復術的應用範圍不斷擴大，使其能夠惠及那些傳統上被認為不適合開胸手術的高風險患者群體。

了解關稅變化引發的複雜供應鏈重組和採購行為：醫療設備採購和醫院採購策略的轉型

2025年實施的關稅調整對醫療設備供應鏈產生了多方面的影響，波及到瓣環成形術成形環生態系統，影響了籌資策略、採購實務和商業規劃。部分零件和成品進口關稅的提高迫使製造商重新評估其全球採購結構，加速了鄰近地區的生產擴張和供應商多元化，以降低貿易政策波動的風險。同時，醫院和醫療系統對採購的審查力度加大，促使企業尋求簽訂長期合約和聯合預測，以平抑成本波動並確保獲得先進的修復技術。

基於深度細分的洞察，能夠明確臨床需求、設備設計權衡以及針對不同手術流程和最終用戶環境的商業化路徑。

細分市場層面的趨勢揭示了微妙的臨床和商業槓桿作用，這些槓桿作用指導著產品開發和市場定位。根據應用領域，二尖瓣修復和三尖瓣修復之間存在差異。二尖瓣手術可細分為退化性逆流和功能性逆流，而三尖瓣手術則分為原發性三尖瓣逆流和繼發續發性三尖瓣逆流。每個臨床亞類對瓣環的尺寸、貼合度和耐用性都有不同的要求。就瓣環形狀而言，產品設計選擇——柔軟性、剛性和半剛性——體現了在維持生理運動和瓣環穩定性之間的權衡，這影響外科醫生的偏好和患者的選擇。

不同關鍵區域的臨床重點、監管體系和採購行為如何推動客製化產品策略和推廣路徑

區域趨勢將影響環狀成形術環相關人員的採納曲線和策略重點。每個地區都有其獨特的臨床實踐、法律規範和醫療保健系統獎勵。在美洲，臨床重點通常在於儘早採用微創技術和強大的心臟外科網路，因此傾向於選擇有助於患者更快康復和縮短住院時間的器械。同時，在歐洲、中東和非洲地區（EMEA），監管路徑和採購機制存在差異，需要可調整的證據包和區域性商業模式，以適應不同的報銷標準和醫院採購習慣。

醫療器材製造商的競爭定位和策略部署正在影響外科醫生的偏好、臨床證據的優先順序以及夥伴關係主導的成長策略。

環狀成形術環領域的競爭動態主要由成熟製造商、專業器材公司和新興創新者組成，每家公司都力求打造差異化的價值提案。成熟公司利用長期建立的臨床關係、廣泛的分銷網路和豐富的臨床數據，在手術量大的中心贏得青睞；而小規模的專業公司則往往透過新型材料、獨特的幾何形狀或與微創輸送系統的整合來尋求利基市場定位。新興參與企業傾向於關注模組化和易於植入的特點，以此來推動外科醫生採用，並強調縮短手術時間和與現代影像技術的兼容性。

器械製造商和醫療保健系統可採取的實際策略行動，以加速瓣膜修復療法的應用、產生證據並增強供應鏈韌性

在瓣環成形術術器材領域尋求長期競爭優勢的產業領導者，應採取一系列切實可行的策略，使產品創新與臨床工作流程和支付方的期望相契合。優先投資於能夠簡化植入操作的設計，以支持微創和開放手術的廣泛應用，同時保持瓣膜的生理運動。此外，還應建立強力的臨床證據項目，包括真實世界註冊研究和性能比較研究，以展示長期療效並為醫保報銷談判提供依據。

我們採用嚴謹的多方法研究框架，整合臨床醫師訪談、監管審查和多資訊來源三角測量，以檢驗設備見解和策略意義。

本調查方法結合了定性和定量技術，以確保獲得嚴謹透明的洞見，從而為策略決策提供基礎。主要研究包括對心臟外科醫生、採購主管和臨床研究人員進行深度訪談，以收集關於器械性能、手術偏好和推廣障礙的第一線觀點。此外，還透過對外科技術文獻和器械標籤的觀察性審查，分析了設計特徵與臨床結果之間的關係。次要研究則涵蓋了同行評審的臨床研究、監管申報文件和技術白皮書，以檢驗器械特性和長期安全性。

該報告整合了臨床、商業和價值鏈主題，提出了以設計主導的差異化、以證據為基礎的採用和協作價值創造。

總之，環狀成形術環的創新正朝著維持生理運動和手術實用性之間取得平衡的方向發展。不斷發展的手術技術和對長期療效日益重視為此提供了支持。器械的差異化越來越依賴材料科學、植入物幾何形狀以及與微創輸送系統的兼容性，而實證醫學證據的累積和培訓計畫則是市場接受度的關鍵。在貿易政策變化和採購審查日益嚴格的背景下，供應鏈韌性和本地化生產正從戰術性考慮轉變為戰略要務。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按環類型分類的醫用心臟環狀成形術環市場

  • 靈活的
  • 剛性
  • 半剛性

9. 依產品類型分類的醫用心臟環狀成形術環市場

  • 完整環
  • 部分環

第10章 依手術類型分類的醫用心臟環狀成形術環市場

  • 微創手術
    • 機器人輔助
    • 胸腔鏡手術
  • 開胸手術

第11章 依材料類型分類的醫用心臟環狀成形術環市場

  • 聚酯纖維
  • PTFE

第12章 按應用分類的醫用心臟環狀成形術環市場

  • 二尖瓣修復
    • 退化性逆流
    • 功能性逆流
  • 三尖瓣修復
    • 原發性三尖瓣逆流
    • 繼發性次發性逆流

第13章 依最終使用者分類的醫用心臟環狀成形術環市場

  • 門診手術中心
  • 心臟外科中心
  • 醫院

第14章 區域性心臟環狀成形術環市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 醫療心臟環狀成形術環市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國醫用心臟環狀成形術環市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國醫用心臟環狀成形術環市場

第18章：中國醫用心臟環狀成形術環市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AtriCure, Inc.
  • B. Braun Melsungen AG
  • Balton SA
  • BioStable Science & Engineering LLC
  • BioVentrix, Inc.
  • Cardiac Science Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Geister Medizintechnik GmbH
  • HeartWare International, Inc.
  • Jotec GmbH
  • Kardia Medical, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LifeLine Cardiology, Inc.
  • LivaNova plc
  • Medistim ASA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Peijia Medical Technology Co., Ltd.
  • Shenzhen Weigao Group Medical Polymer Company Limited
  • St. Jude Medical, Inc.
  • Terumo Corporation
Product Code: MRR-F14BA1B34199

The Medical Heart Annuloplasty Ring Market was valued at USD 448.89 million in 2025 and is projected to grow to USD 473.50 million in 2026, with a CAGR of 4.28%, reaching USD 602.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 448.89 million
Estimated Year [2026] USD 473.50 million
Forecast Year [2032] USD 602.18 million
CAGR (%) 4.28%

A strategic primer presenting clinical drivers, device design evolution, and healthcare system dynamics shaping annuloplasty ring development and adoption

This executive summary distills the strategic considerations surrounding heart annuloplasty rings, emphasizing clinical innovation, device design evolution, and evolving care pathways. It synthesizes current practice patterns, device differentiation, and stakeholder incentives to provide a clear foundation for executive decision-making. The analysis prioritizes clinical drivers such as the increasing preference for valve-preserving therapies, material science advances fostering biocompatibility, and procedural shifts toward less invasive approaches that aim to reduce perioperative risk and accelerate patient recovery.

In addition, the summary highlights how regulatory scrutiny and reimbursement frameworks shape product development priorities, influencing design choices and clinical evidence generation. It also outlines the competitive dynamics that arise from new entrants and incremental innovation, clarifying how established manufacturers and innovative device companies position their portfolios across clinical subsegments. Ultimately, the introduction sets the stage for deeper insights by framing the interplay between clinical need, engineering solutions, and health system adoption, enabling stakeholders to align product, clinical trials, and commercialization strategies with emerging provider expectations and patient outcomes.

How advancements in device design, procedural innovation, and clinical training are collectively redefining expectations and adoption pathways for annuloplasty rings

The landscape for annuloplasty rings has experienced transformative shifts driven by technological refinement, procedural innovation, and changing clinician preferences. Advances in ring geometry and material science have enabled designs that better mimic native annular dynamics, thereby improving repair durability and functional outcomes. Simultaneously, procedural innovation has accelerated the movement toward minimally invasive access, where surgical techniques and adjunctive imaging converge to expand the candidacy for valve repair in patients once deemed high risk for open procedures.

Moreover, talent diffusion across cardiac surgery teams and investment in surgeon training programs have reduced variability in procedural outcomes, which in turn has emboldened clinical adoption of newer ring designs. On the regulatory front, governing bodies have encouraged robust post-market surveillance and real-world evidence generation, nudging manufacturers to invest in longitudinal follow-up and registries. These combined shifts have reshaped value propositions: where once durability and basic hemodynamics dominated, contemporary differentiation now rests on ease of implantation, physiologic motion preservation, and compatibility with minimally invasive platforms. Consequently, companies and providers that anticipate these combined forces and invest in integrated solutions stand to influence standard-of-care trajectories.

Understanding the complex supply chain realignment and procurement behaviors triggered by tariff changes that reshaped device sourcing and hospital purchasing strategies

The advent of tariff adjustments affecting medical device supply chains in 2025 introduced multifaceted implications for the annuloplasty ring ecosystem, influencing sourcing strategies, procurement practices, and commercial planning. Higher import duties on certain components and finished devices prompted manufacturers to re-evaluate global sourcing footprints, accelerating near-shore production and supplier diversification to mitigate exposure to trade policy fluctuations. At the same time, increased procurement scrutiny by hospitals and health systems encouraged longer-term contracting and collaborative forecasting to smooth cost volatility and preserve access to advanced repair technologies.

Clinically, providers seeking to manage device spend without compromising patient care began emphasizing product selection frameworks that balance device performance with total procedural cost. Payers and hospital procurement teams intensified evaluations of cost-effectiveness and supply chain resilience, which in turn affected formulary placement and purchasing agreements. For device innovators, tariff-driven cost pressures underscored the strategic value of modular product architectures and local manufacturing partnerships that can bypass tariff layers while maintaining quality controls. In summary, the cumulative tariff impact catalyzed supply chain realignment, reshaped procurement behaviors, and elevated strategic conversations about manufacturing localization and lifecycle cost management.

Deep segmentation-driven insights that clarify clinical requirements, device design trade-offs, and targeted commercialization pathways across diverse procedural and end-user contexts

Segment-level dynamics reveal nuanced clinical and commercial levers that guide product development and market positioning. Based on application, differentiation emerges across mitral valve repair and tricuspid valve repair, where mitral interventions subdivide into degenerative regurgitation and functional regurgitation, and tricuspid interventions divide into primary tricuspid regurgitation and secondary tricuspid regurgitation; each of these clinical subcategories imposes distinct demands on ring sizing, conformability, and durability. In terms of ring shape, product design choices among flexible, rigid, and semi-rigid options reflect trade-offs between physiologic motion preservation and annular stabilization, affecting surgeon preference and patient selection.

Product type segmentation between complete ring and partial ring drives implantation strategies and intraoperative workflow, while procedure type distinctions between minimally invasive procedures and open heart procedures-where minimally invasive approaches further include robotic assisted and thoracoscopic techniques-shape device delivery systems, training requirements, and instrumentation ecosystems. End user segmentation across ambulatory surgical centers, cardiac surgery centers, and hospitals influences procurement cycles, case mix, and capital equipment planning. Finally, material type considerations such as polyester versus PTFE underpin long-term biocompatibility, suture handling, and tissue integration profiles, guiding both regulatory strategy and clinical messaging. Together, these segments inform targeted clinical evidence generation, differentiated go-to-market strategies, and prioritized R&D investments.

How distinct clinical priorities, regulatory systems, and procurement behaviors across major global regions drive tailored product strategies and adoption pathways

Regional dynamics shape adoption curves and strategic priorities for annuloplasty ring stakeholders, with each geography presenting distinct clinical practices, regulatory frameworks, and health system incentives. In the Americas, clinical emphasis often centers on early adoption of minimally invasive techniques and robust cardiac surgery networks, which favor devices that support rapid recovery and reduced length of stay. Conversely, Europe, Middle East & Africa exhibits heterogeneity in regulatory pathways and procurement mechanisms, requiring adaptable evidence packages and region-specific commercial models to address varying reimbursement norms and hospital purchasing practices.

Asia-Pacific markets combine rapidly expanding procedural volumes with an increasing emphasis on domestic manufacturing and regional clinical training programs, which encourages manufacturers to tailor product offerings and service models for scale and affordability. Across all regions, collaborative partnerships with local clinical leaders and investment in training programs have proven effective in accelerating uptake. Transitioning from regional observations to actionable strategy, manufacturers should calibrate regulatory submissions, build localized evidence generation, and structure commercial operations to reflect each region's distinct mix of clinical need, purchasing behavior, and health system complexity.

Competitive positioning and strategic maneuvers by device makers shaping surgeon preference, clinical evidence priorities, and partnership-driven growth strategies

Competitive dynamics in the annuloplasty ring arena center on a mixture of legacy manufacturers, specialized device firms, and emerging innovators, each pursuing differentiated value propositions. Established companies leverage long-standing clinical relationships, extensive distribution networks, and a breadth of clinical data to secure preference in high-volume centers, while smaller specialists often seek niche positioning through novel materials, proprietary geometries, or integration with minimally invasive delivery systems. Emerging entrants tend to focus on modularity and ease of implantation as a route to surgeon adoption, emphasizing reduced procedural time and compatibility with contemporary imaging modalities.

Strategic partnerships and targeted acquisitions have become common tactics to fill portfolio gaps, accelerate entry into minimally invasive markets, and extend service offerings. Additionally, firms investing in longitudinal real-world evidence and registries strengthen clinical credibility and payer conversations. For purchasing institutions, the vendor selection process increasingly evaluates not only product performance but also training support, supply chain resilience, and lifecycle cost transparency. Collectively, these factors are shaping competitive positioning and informing where companies choose to invest in clinical research, manufacturing capabilities, and commercial enablement.

Practical strategic actions for device manufacturers and health systems to enhance adoption, evidence generation, and supply chain resilience in valve repair therapies

Industry leaders aiming to secure long-term relevance in annuloplasty devices should pursue a set of actionable strategies that align product innovation with clinical workflows and payer expectations. Prioritize investment in designs that preserve physiologic annular motion while simplifying implantation to support wider adoption across both minimally invasive and open approaches. Concurrently, build robust clinical evidence programs that include real-world registries and comparative performance studies to demonstrate long-term outcomes and inform reimbursement discussions.

Operationally, strengthen supplier diversity and consider regional manufacturing partnerships to hedge against trade-related disruptions and to meet local procurement preferences. Complement these moves with surgeon-focused training initiatives and proctorship programs that reduce the learning curve for new techniques and devices. Finally, develop comprehensive value communication packages that translate clinical benefits into economic terms meaningful to hospital administrators and payers, emphasizing reduced complications, shorter stays, and procedural efficiency. Executed together, these actions will help manufacturers and health systems align on sustainable adoption pathways and deliver measurable improvements in patient care.

A rigorous multi-method research framework that integrates clinician interviews, regulatory review, and cross-source triangulation to validate device insights and strategic implications

The research methodology combines qualitative and quantitative techniques to ensure rigorous, transparent findings that inform strategic decision-making. Primary research included in-depth interviews with cardiac surgeons, procurement leaders, and clinical researchers to capture first-hand perspectives on device performance, procedural preferences, and adoption barriers. These conversations were supplemented by observational review of surgical technique literature and device labeling to map design features to clinical outcomes. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, and technical white papers to validate device attributes and long-term safety profiles.

Data synthesis employed triangulation across sources to reconcile differing viewpoints and to identify persistent themes. Where appropriate, sensitivity analyses were used to explore how changes in clinical practice or procurement policies could alter adoption dynamics. Quality assurance procedures included cross-validation of interview findings against clinical publications and consultation with independent clinical experts to ensure interpretation fidelity. This layered approach provides a robust foundation for the conclusions and recommendations presented in the report, while maintaining transparency about data sources and analytical assumptions.

Synthesis of clinical, commercial, and supply chain themes pointing to design-led differentiation, evidence-driven adoption, and collaborative value articulation

In conclusion, annuloplasty ring innovation is converging toward solutions that balance physiologic motion preservation with surgical practicality, supported by evolving procedural techniques and heightened attention to long-term outcomes. Device differentiation will increasingly depend on a combination of material science, implant geometry, and compatibility with minimally invasive delivery systems, while evidence generation and training programs will be pivotal for market acceptance. Supply chain resilience and localized manufacturing have moved from tactical considerations to strategic imperatives in light of shifting trade policies and procurement scrutiny.

Looking ahead, manufacturers that integrate clinical evidence strategies with surgeon-centric design and robust commercial support will be best positioned to influence clinical practice and secure durable adoption. Health systems and payers will continue to demand transparent value narratives that align patient outcomes with economic realities, encouraging collaborations that link device innovation with measurable improvements in care pathways. Taken together, these themes underscore a pathway for stakeholders to translate technical advancements into better patient outcomes and sustainable commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Heart Annuloplasty Ring Market, by Ring Shape

  • 8.1. Flexible
  • 8.2. Rigid
  • 8.3. Semi-Rigid

9. Medical Heart Annuloplasty Ring Market, by Product Type

  • 9.1. Complete Ring
  • 9.2. Partial Ring

10. Medical Heart Annuloplasty Ring Market, by Procedure Type

  • 10.1. Minimally Invasive Procedure
    • 10.1.1. Robotic Assisted
    • 10.1.2. Thoracoscopic
  • 10.2. Open Heart Procedure

11. Medical Heart Annuloplasty Ring Market, by Material Type

  • 11.1. Polyester
  • 11.2. PTFE

12. Medical Heart Annuloplasty Ring Market, by Application

  • 12.1. Mitral Valve Repair
    • 12.1.1. Degenerative Regurgitation
    • 12.1.2. Functional Regurgitation
  • 12.2. Tricuspid Valve Repair
    • 12.2.1. Primary Tricuspid Regurgitation
    • 12.2.2. Secondary Tricuspid Regurgitation

13. Medical Heart Annuloplasty Ring Market, by End User

  • 13.1. Ambulatory Surgical Center
  • 13.2. Cardiac Surgery Center
  • 13.3. Hospital

14. Medical Heart Annuloplasty Ring Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Medical Heart Annuloplasty Ring Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Medical Heart Annuloplasty Ring Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Medical Heart Annuloplasty Ring Market

18. China Medical Heart Annuloplasty Ring Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AtriCure, Inc.
  • 19.7. B. Braun Melsungen AG
  • 19.8. Balton S.A.
  • 19.9. BioStable Science & Engineering LLC
  • 19.10. BioVentrix, Inc.
  • 19.11. Cardiac Science Corporation
  • 19.12. CryoLife, Inc.
  • 19.13. Edwards Lifesciences Corporation
  • 19.14. Geister Medizintechnik GmbH
  • 19.15. HeartWare International, Inc.
  • 19.16. Jotec GmbH
  • 19.17. Kardia Medical, Inc.
  • 19.18. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.19. LifeLine Cardiology, Inc.
  • 19.20. LivaNova plc
  • 19.21. Medistim ASA
  • 19.22. Medtronic plc
  • 19.23. MicroPort Scientific Corporation
  • 19.24. Peijia Medical Technology Co., Ltd.
  • 19.25. Shenzhen Weigao Group Medical Polymer Company Limited
  • 19.26. St. Jude Medical, Inc.
  • 19.27. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SEMI-RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COMPLETE RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PARTIAL RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY THORACOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY OPEN HEART PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY DEGENERATIVE REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY FUNCTIONAL REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRIMARY TRICUSPID REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SECONDARY TRICUSPID REGURGITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY CARDIAC SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 171. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 201. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 202. G7 MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 211. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 212. NATO MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY RING SHAPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA MEDICAL HEART ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)